Functional mitral regurgitation (FMR) is a ventricular disease characterized by mitral valve insufficiency in the absence of structural abnormalities of the valve leaflets or sub-valvular apparatus.1 It commonly provokes heart failure and frequently confers an increase in patient mortality and morbidity. Medical therapy has a limited role for management of FMR. When treated, FMR is currently managed exclusively through open heart surgical techniques.
FMR may occur either in the presence of non-ischaemic dilated cardiomyopathy or in patients with regional wall motion abnormalities due to underlying ischaemic heart disease. More specifically, FMR results not only from ...
From measuring stress in bioprosthetic valve leaflets, IABP vs inotropes or data from AIDA and the MeRes-1 trials
(Cover Image: VIC-3D displacement representation)
September 20, 2019